Industry update Mydecine to make first legal import of psilocybin mushrooms into Canada Canada continues to open the door for clinical research the effectiveness of psilocybin for mental health treatments Jared GnamDecember 11, 2020
The weed wire Mydecine gets first CGMP status to produce, sell and export medical psilocybin The Denver-based company says the new milestone will advance global research for medical psilocybin as depression rises during the pandemic Jared GnamAugust 19, 2020
The weed wire Mushroom company Mydecine acquires veteran-focused psychedelic firm With deep Canadian and U.S. military ties, NeuroPharm Inc. is about to launch psychedelic-based clinical trials Jared GnamJuly 15, 2020